logo
Plus   Neg
Share
Email

Verisk Q1 Profit Falls, Revenue Up

Data analytics provider Verisk Analytics, Inc., (VRSK) on Tuesday posted first-quarter net income of $168 million or $1.03 per share, down from $172 million or $1.04 per share in the previous-year quarter.

Adjusted earnings per share rose 5.1 percent to $1.23 from $1.17 a year ago.
On average, 14 analysts polled by Thomson Reuters expected the company to report earnings of $1.25 per share in the period. Analysts' estimates, usually, exclude one-time items.

Quarterly revenues climbed 5.3 percent to $726.1 million from $689.9 million in the prior-year period while analysts were looking for revenues of $725.6 million.

The company's Board of Directors approved a cash dividend of $0.29 per share payable on June 30.

Commenting on the results, Lee Shavel, CFO and Group President, said, "Verisk delivered organic constant currency revenue growth of 3.4 percent and organic constant currency adjusted EBITDA growth of 5.2 percent in the first quarter, led by continued strength in our insurance business."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Fashion retailer L Brands, Inc. announced Tuesday that its Board of Directors has unanimously approved a plan to separate the company into two independent publicly traded companies. The two public companies will be Bath & Body Works, one of the world's leading bath, body and home fragrance retailers, and Victoria's Secret, including Victoria's Secret Lingerie, PINK and Victoria's Secret Beauty. Danish pharmaceutical company Novo Nordisk A/S is recalling 1,468 product samples of Levemir, Tresiba, Fiasp, Novolog and Xultophy to the consumer level, due to improper storage temperature conditions, the U.S. Food and Drug Administration said. The Food and Drug Administration on Monday expanded the emergency use authorization of Pfizer-BioNTech's Covid-19 vaccine to include 12- to 15-year-olds. "The FDA's expansion of the emergency use authorization for the Pfizer-BioNTech COVID-19 Vaccine to include adolescents 12 through 15 years of age...
Follow RTT